Marksans Pharma Ltd has announced regarding USFDA verification of NDMA in Metformin Extended Release Tablets.
The company has submitted its preliminary response to US FDA on the same and are further communicating with them.
For the last year ended 31% March 2020, our Exports to USA for the Metformin Extended Release Tablets were of USD 1.43 million only which constitutes less than 1% of its Consolidated Revenue.
Shares of MARKSANS PHARMA LTD. was last trading in BSE at Rs.22.65 as compared to the previous close of Rs. 20.9. The total number of shares traded during the day was 497716 in over 1082 trades.
The stock hit an intraday high of Rs. 22.95 and intraday low of 21.25. The net turnover during the day was Rs. 11165861.